Answers are grounded in this paper and cite their sources.
Demonstrates effective radionuclide delivery in glioblastoma, suggesting novel therapeutic approaches.
I]IUdR, supporting a sustained release profile. DNA incorporation assays and viability studies in glioblastoma cells confirmed the biological activity and radiotoxicity of the released compound. This work highlights the potential of PeptoBrushes for controlled radionuclide delivery of Auger-emitting radiotherapeutic agents, laying the foundation for an innovative strategy in glioblastoma therapy.
No takes yet. Share an insight, caveat, or question.
Schäfer et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: